Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The successful implementation of comprehensive control paradigm for eliminating leprosy in Yunnan Province, China

Ma T, Zhen Q, Guo F, et al. Elsevier BV. Journal of Infection. 2025; 90 (6) : 1-7.
Download PDF
Publication

Distribuição espacial e perfis epidemiológicos da hanseníase em Anápolis (GO): um estudo de 2019-2024

Castro IDOE, Castro LC, Chaul SFM, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2025;
Download PDF
Publication

A IMPORTÂNCIA DA ATUAÇÃO FARMACÊUTICA NA ABORDAGEM MULTIDISCIPLINAR DE PACIENTES COM HANSENÍASE

GAMA SIQUEIRA G, SARAIVA DE ANDRADE RODRIGUES R. Guilherme Barroso L. De Freitas. Imunologia e Doenças Infecciosas e Parasitárias - Edição III. 2025;
Download PDF
Publication

Ensino da hanseníase nas faculdades de medicina de um estado com baixa endemicidade

Vitiritti Ferreira Zanardo B, Baruffi PP, Ens RT. Universidade Estadual do Parana - Unespar. Ensino & Pesquisa. 2025; 23 (1) : 712-723.
Download PDF
Publication

Leprosy: health education with children and adolescents – systematic review / Hanseníase: educação em saúde com crianças e adolescentes – revisão sistemática

Francisco MM, Albuquerque MIND, Santos LMDS, et al. Universidade Federal do Estado do Rio de Janeiro UNIRIO. Revista de Pesquisa Cuidado é Fundamental Online. 2025;
Download PDF
Publication

Leprosy with comorbidities: A call for strengthening vigilance

Ramasamy S, Panneerselvam S, Agrawal S. Ovid Technologies (Wolters Kluwer Health). Journal of Family Medicine and Primary Care. 2025; 14 (4) : 1572-1573.
Download PDF
Practical material

DHIS2-based leprosy/Hansen disease Elimination Monitoring Tool (‎LEMT)‎ – Standard operating procedures

WHO Regional Office South-East Asia . 2025;
Access resource
Publication

Borderline lepromatous leprosy with lymph node infiltration: Dermatology helps to clarify challenging diagnoses

Reis VHMD, Miola AC, Ferreira CAZ, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2025;
Download PDF
Publication

Challenges and opportunities in the development and implementation of zero leprosy roadmaps in low-endemic settings: Experiences from Bolivia, Pakistan, and Togo

Fastenau A, Schwermann F, Mora AB, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025; 19 (4) : e0013009.
Download PDF
Publication

Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin

Djossou P, Mignanwande ZFM, Anagonou SGE, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025; 19 (4) : e0013057.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 7
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD